Skip to main content
logo
Soleno Therapeutics, Inc. (SLNO)
May 18, 2026 - SLNO was delisted (reason: acquired by NBIX)
53.01
0.00 (0.00%)
Inactive · Last trade price on May 15, 2026

Soleno Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2,7632,4212,0541,27581164
Market Cap Growth
-19.91%17.84%61.12%1478.46%-50.66%-78.69%
Enterprise Value
2,2882,1671,8151,10566.18142.59
Last Close Price
53.0146.3044.9540.259.9030.75

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
30.00118.72----
Forward PE
11.1613.68----
PS Ratio
9.6912.71----
PB Ratio
5.535.388.388.107.819.20
P/FCF Ratio
26.2151.81----
P/OCF Ratio
26.1851.73----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
8.0311.38----
EV/EBITDA Ratio
25.00189.59----
EV/EBIT Ratio
25.57230.21----
EV/FCF Ratio
21.7146.38----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.110.120.210.0000.01
Debt / EBITDA Ratio
0.614.60----
Debt / FCF Ratio
0.521.13----
Net Debt / Equity Ratio
-0.41-0.56-0.97-1.07-1.40-1.17
Net Debt / EBITDA Ratio
-2.28-22.131.294.290.640.71
Net Debt / FCF Ratio
-1.91-5.413.446.790.700.75
Asset Turnover
0.490.430000
Inventory Turnover
0.240.36----
Quick Ratio
5.225.4415.5514.752.002.66
Current Ratio
5.625.8015.6814.892.142.80
Return on Equity (ROE)
20.31%6.01%-87.35%-46.45%-171.05%-97.60%
Return on Assets (ROA)
14.22%2.10%-73.36%-39.95%-78.64%-62.72%
Return on Invested Capital (ROIC)
29.20%7.18%-1379.43%-1262.86%-404.32%-440.27%
Return on Capital Employed (ROCE)
16.42%2.31%-77.97%-43.94%-104.42%-75.15%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
3.46%0.84%----
FCF Yield
3.82%1.93%----
Buyback Yield / Dilution
-26.81%-30.39%-143.61%-96.40%-57.90%-27.39%
Total Shareholder Return
-26.81%-30.39%-143.61%-96.40%-57.90%-27.39%
SEC Filings: 10-K · 10-Q